Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor

International Forum of Allergy and Rhinology

Volumn 5, Issue 2, 2015, Pages 178-181

  Chang, Eugene H ^a   Tang, Xiao Xiao ^a   Shah, Viral S ^a   Launspach, Janice L ^a   Ernst, Sarah E ^a   Hilkin, Brieanna ^a   Karp, Philip H ^a   Abou Alaiwa, Mahmoud H ^a   Graham, Scott M ^a   Hornick, Douglas B ^a   Welsh, Michael J ^a   Stoltz, David A ^a   Zabner, Joseph ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Airway surface liquid; ASL; CF; CFTR; Cystic fibrosis; Ivacaftor

Indexed keywords

ANTIBIOTIC AGENT; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; IVACAFTOR; AMINOPHENOL DERIVATIVE; ANTIINFLAMMATORY AGENT; QUINOLONE DERIVATIVE;

ADULT; AIRWAY SURFACE LIQUID; ALLELE; ARTICLE; BODY FLUID; BRONCHIECTASIS; CASE REPORT; CFTR GENE; CHILD; CHRONIC COUGH; CHRONIC SINUSITIS; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DYSPNEA; ELECTRIC POTENTIAL; ENDOSCOPIC SURGERY; EPITHELIUM CELL; ETHMOID SINUS; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FORCED EXPIRATORY VOLUME; FRONTAL SINUS; GENE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEADACHE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ION TRANSPORT; LUNG LAVAGE; MAXILLARY SINUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOCELE; MUTATIONAL ANALYSIS; NASAL BIOPSY; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PH; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPIROMETRY; VISCOSITY; YOUNG ADULT; CELL CULTURE; CHRONIC DISEASE; COMPLICATION; DEFICIENCY; DRUG EFFECTS; GENETICS; MUTATION; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; SINUSITIS; TREATMENT OUTCOME;

AMINOPHENOLS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CHILD; CHRONIC DISEASE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; ION TRANSPORT; MUTATION; QUINOLONES; RESPIRATORY MUCOSA; SINUSITIS; TREATMENT OUTCOME; VISCOSITY;

EID: 84922515561     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21440     Document Type: Article

References (25)

1. King VV. Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy. 1991;9:143-157.
2. Mainz JG, Naehrlich L, Schien M, et al. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax. 2009;64:535-540.
3. McMurphy AB, Morriss C, Roberts DB, Friedman EM. The usefulness of computed tomography scans in cystic fibrosis patients with chronic sinusitis. Am J Rhinol. 2007;21:706-710.
4. Eggesbo HB, Sovik S, Dolvik S, Kolmannskog F. CT characterization of inflammatory paranasal sinus disease in cystic fibrosis. Acta Radiol. 2002;43:21-28.
5. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
6. Welsh MJ, Ramsey BW, Accurso F, et al., eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 2001.
7. Jih KY, Hwang TC. Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle. Proc Natl Acad Sci U S A. 2013;110:4404-4409.
8. Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363:1991-2003.
9. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14.
10. Standaert TA, Boitano L, Emerson J, et al. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol. 2004;37:385-392.
11. Abou Alaiwa MH, Beer AM, Pezzulo AA, et al. Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study. J Cyst Fibros. 2014;13:373-377.
12. Karp PH, Moninger TO, Weber SP, et al. An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures. Methods Mol Biol. 2002;188:115-137.
13. Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A. 2009;106:18825-18830.
14. Pezzulo AA, Tang XX, Hoegger MJ, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487:109-113.
15. Derichs N, Jin BJ, Song Y, Finkbeiner WE, Verkman AS. Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching. FASEB J. 2011;25:2325-2332.
16. Illek B, Zhang L, Lewis NC, Moss RB, Dong JY, Fischer H. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am J Physiol. 1999;277:C833-C839.
17. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest. 1992;89:1148-1153.
18. Coakley RD, Grubb BR, Paradiso AM, et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci U S A. 2003;100:16083-16088.
19. Chang EH, Pezzulo AA, Meyerholz DK, et al. Sinus hypoplasia precedes sinus infection in a porcine model of cystic fibrosis. Laryngoscope. 2012;122:1898-1905.
20. Chillon M, Casals T, Nunes V, Gimenez J, Perez Ruiz E, Estivill X. Identification of a new missense mutation (P205S) in the first transmembrane domain of the CFTR gene associated with a mild cystic fibrosis phenotype. Hum Mol Genet. 1993;2:1741-1742.
21. Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA. 2000;284:1814-1819.
22. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg. 2000;126:940-946.
23. Cantin AM, Hanrahan JW, Bilodeau G, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006;173:1139-1144.
24. Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10. 2009;(242):1-157.
25. Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med. 2012;209:1263-1272.